These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 11071774

  • 1. VEGF spatially directs angiogenesis during metanephric development in vitro.
    Tufró A.
    Dev Biol; 2000 Nov 15; 227(2):558-66. PubMed ID: 11071774
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
    Grosskreutz CL, Anand-Apte B, Dupláa C, Quinn TP, Terman BI, Zetter B, D'Amore PA.
    Microvasc Res; 1999 Sep 15; 58(2):128-36. PubMed ID: 10458928
    [Abstract] [Full Text] [Related]

  • 4. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H, Jezequel S, Löhr M, Shaikh S, Davis D, Soker S, Selwood D, Zachary I.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):164-73. PubMed ID: 11322784
    [Abstract] [Full Text] [Related]

  • 5. Neovascularization of the Xenopus embryo.
    Cleaver O, Tonissen KF, Saha MS, Krieg PA.
    Dev Dyn; 1997 Sep 27; 210(1):66-77. PubMed ID: 9286596
    [Abstract] [Full Text] [Related]

  • 6. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 7. Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: a role for vascular endothelial growth factor as a survival factor for endothelium.
    Mitchell CA, Risau W, Drexler HC.
    Dev Dyn; 1998 Nov 01; 213(3):322-33. PubMed ID: 9825867
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid-induced angiogenesis is VEGF-dependent.
    Carter WB, Uy K, Ward MD, Hoying JB.
    Surgery; 2000 Sep 01; 128(3):458-64. PubMed ID: 10965318
    [Abstract] [Full Text] [Related]

  • 9. Modulation of cell migration and vessel formation by vascular endothelial growth factor and basic fibroblast growth factor in cultured embryonic heart.
    Ratajska A, Torry RJ, Kitten GT, Kolker SJ, Tomanek RJ.
    Dev Dyn; 1995 Aug 01; 203(4):399-407. PubMed ID: 7496032
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T.
    Circ Res; 2003 Sep 05; 93(5):438-47. PubMed ID: 12881481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N.
    Am J Pathol; 2001 Aug 05; 159(2):599-608. PubMed ID: 11485918
    [Abstract] [Full Text] [Related]

  • 13. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
    Clin Cancer Res; 2002 Apr 05; 8(4):1242-50. PubMed ID: 11948139
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 01; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 Dec 01; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 17. Multiple differentiation pathways of rat mammary stromal cells in vitro: acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation.
    Zangani D, Darcy KM, Masso-Welch PA, Bellamy ES, Desole MS, Ip MM.
    Differentiation; 1999 Jan 01; 64(2):91-101. PubMed ID: 10234806
    [Abstract] [Full Text] [Related]

  • 18. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 01; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 19. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J.
    Mol Cancer Res; 2002 Nov 01; 1(1):2-11. PubMed ID: 12496364
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S.
    Med Sci Monit; 2000 Nov 01; 6(5):1047-52. PubMed ID: 11208453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.